Your search for bevacizumab returned 1 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Mital Patel, PharmD remove
Drugs in the Pipeline remove

Your search for bevacizumab returned 1 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

CRLX101 Fast Tracked for Metastatic Renal Cell Carcinoma

The Food and Drug Administration (FDA) has granted Fast Track designation to CRLX101 (Cerulean Pharma) in combination with Avastin (bevacizumab) for the treatment of metastatic renal cell carcinoma (mRCC) following progression through two or three prior lines of therapy.